| Parameter . | Univariate . | Multivariate [0.834 (0.090)a] . | ||
|---|---|---|---|---|
| HR (95% CI) . | P-value . | HR (95% CI) . | P-value . | |
| Clinical parameters | ||||
| Age | 1.012 (0.966–1.060) | 0.624 | ||
| Age >75 years | 1.770 (0.226–13.835) | 0.586 | ||
| Male gender | 4.255 (0.544–33.247) | 0.168 | 2.812 (0.353–22.388) | 0.329 |
| Hypertension | 1.101 (0.336–3.608) | 0.874 | ||
| Diabetes | 0.433 (0.055–3.383) | 0.425 | ||
| LA size | 1.040 (0.935–1.157) | 0.473 | ||
| LA volume index | 1.005 (0.938–1.078) | 0.883 | ||
| LVEF | 0.974 (0.930–1.020) | 0.262 | ||
| E/Em | 0.973 (0.825–1.148) | 0.749 | ||
| CHADS2 score | 0.938 (0.491–1.792) | 0.846 | ||
| Group parameter | ||||
| CPVI + SVC-L | 0.178 (0.038–0.824) | 0.027 | 0.093 (0.014–0.646) | 0.016 |
| Parameter . | Univariate . | Multivariate [0.834 (0.090)a] . | ||
|---|---|---|---|---|
| HR (95% CI) . | P-value . | HR (95% CI) . | P-value . | |
| Clinical parameters | ||||
| Age | 1.012 (0.966–1.060) | 0.624 | ||
| Age >75 years | 1.770 (0.226–13.835) | 0.586 | ||
| Male gender | 4.255 (0.544–33.247) | 0.168 | 2.812 (0.353–22.388) | 0.329 |
| Hypertension | 1.101 (0.336–3.608) | 0.874 | ||
| Diabetes | 0.433 (0.055–3.383) | 0.425 | ||
| LA size | 1.040 (0.935–1.157) | 0.473 | ||
| LA volume index | 1.005 (0.938–1.078) | 0.883 | ||
| LVEF | 0.974 (0.930–1.020) | 0.262 | ||
| E/Em | 0.973 (0.825–1.148) | 0.749 | ||
| CHADS2 score | 0.938 (0.491–1.792) | 0.846 | ||
| Group parameter | ||||
| CPVI + SVC-L | 0.178 (0.038–0.824) | 0.027 | 0.093 (0.014–0.646) | 0.016 |
aC-statistic (SD).
LA, left atrium; LVEF, left ventricular ejection fraction.
| Parameter . | Univariate . | Multivariate [0.834 (0.090)a] . | ||
|---|---|---|---|---|
| HR (95% CI) . | P-value . | HR (95% CI) . | P-value . | |
| Clinical parameters | ||||
| Age | 1.012 (0.966–1.060) | 0.624 | ||
| Age >75 years | 1.770 (0.226–13.835) | 0.586 | ||
| Male gender | 4.255 (0.544–33.247) | 0.168 | 2.812 (0.353–22.388) | 0.329 |
| Hypertension | 1.101 (0.336–3.608) | 0.874 | ||
| Diabetes | 0.433 (0.055–3.383) | 0.425 | ||
| LA size | 1.040 (0.935–1.157) | 0.473 | ||
| LA volume index | 1.005 (0.938–1.078) | 0.883 | ||
| LVEF | 0.974 (0.930–1.020) | 0.262 | ||
| E/Em | 0.973 (0.825–1.148) | 0.749 | ||
| CHADS2 score | 0.938 (0.491–1.792) | 0.846 | ||
| Group parameter | ||||
| CPVI + SVC-L | 0.178 (0.038–0.824) | 0.027 | 0.093 (0.014–0.646) | 0.016 |
| Parameter . | Univariate . | Multivariate [0.834 (0.090)a] . | ||
|---|---|---|---|---|
| HR (95% CI) . | P-value . | HR (95% CI) . | P-value . | |
| Clinical parameters | ||||
| Age | 1.012 (0.966–1.060) | 0.624 | ||
| Age >75 years | 1.770 (0.226–13.835) | 0.586 | ||
| Male gender | 4.255 (0.544–33.247) | 0.168 | 2.812 (0.353–22.388) | 0.329 |
| Hypertension | 1.101 (0.336–3.608) | 0.874 | ||
| Diabetes | 0.433 (0.055–3.383) | 0.425 | ||
| LA size | 1.040 (0.935–1.157) | 0.473 | ||
| LA volume index | 1.005 (0.938–1.078) | 0.883 | ||
| LVEF | 0.974 (0.930–1.020) | 0.262 | ||
| E/Em | 0.973 (0.825–1.148) | 0.749 | ||
| CHADS2 score | 0.938 (0.491–1.792) | 0.846 | ||
| Group parameter | ||||
| CPVI + SVC-L | 0.178 (0.038–0.824) | 0.027 | 0.093 (0.014–0.646) | 0.016 |
aC-statistic (SD).
LA, left atrium; LVEF, left ventricular ejection fraction.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
